Who makes Cefepime 2000 mg?

Cefepime 2000 mg is developed by Wockhardt.

What development phase is Cefepime 2000 mg in?

Cefepime 2000 mg is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Cefepime 2000 mg

Wockhardt · FDA-approved active Small molecule Quality 0/100

At a glance

Generic name	Cefepime 2000 mg
Sponsor	Wockhardt
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients (PHASE4)
Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs) (PHASE2)
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Cefepime 2000 mg CI brief — competitive landscape report
Cefepime 2000 mg updates RSS · CI watch RSS
Wockhardt portfolio CI